{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:09:18Z","timestamp":1785812958333,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR133232"],"award-info":[{"award-number":["NIHR133232"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","award":["RECSM22\/23-22669"],"award-info":[{"award-number":["RECSM22\/23-22669"]}],"id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","award":["10\/03\/2022"],"award-info":[{"award-number":["10\/03\/2022"]}],"id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.preghy.2026.101455","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:26:24Z","timestamp":1774409184000},"page":"101455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prediction of severe maternal and perinatal complications in hypertensive pregnancies using point-of-care glycosylated fibronectin: A prospective cohort study"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6542-2114","authenticated-orcid":false,"given":"Anastasia","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5016-0430","authenticated-orcid":false,"given":"Katy","family":"Kuhrt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Tamba M\u2019Bayoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossetta","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Hurrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7904-7933","authenticated-orcid":false,"given":"Paul T.","family":"Seed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Bramham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5273-3132","authenticated-orcid":false,"given":"Andrew","family":"Shennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2026.101455_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/481095","article-title":"Public Health Perspectives of Preeclampsia in Developing Countries: Implication for Health System Strengthening","volume":"2011","author":"Osungbade","year":"2011","journal-title":"J. Pregnancy"},{"issue":"4","key":"10.1016\/j.preghy.2026.101455_b0010","article-title":"Diagnosis and management of preeclampsia in community settings in low and middle-income countries","volume":"4","author":"Salam","year":"2015","journal-title":"J Family Med Prim Care [Internet]."},{"issue":"9516","key":"10.1016\/j.preghy.2026.101455_b0015","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"The Lancet [Internet]."},{"key":"10.1016\/j.preghy.2026.101455_b0020","unstructured":"World Health Organization. The Global Health Observatory (GHO): Monitoring health for the SDGs. 2017."},{"key":"10.1016\/j.preghy.2026.101455_b0025","unstructured":"United Nations. Population Division, Data Portal . 2020."},{"issue":"19","key":"10.1016\/j.preghy.2026.101455_b0030","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.preghy.2026.101455_b0035","doi-asserted-by":"crossref","first-page":"58.e1","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2026.101455_b0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000359968","article-title":"Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks\u2019 Gestation","volume":"35","author":"Lai","year":"2014","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.preghy.2026.101455_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2020.11.010","article-title":"Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource SeTting: ROBUST study","volume":"23","author":"Soundararajan","year":"2021","journal-title":"Pregnancy Hypertens."},{"issue":"10","key":"10.1016\/j.preghy.2026.101455_b0050","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1161\/HYPERTENSIONAHA.125.24526","article-title":"Point-of-Care Placental Growth Factor for Predicting Adverse Outcomes in Sierra Leone","volume":"82","author":"Kuhrt","year":"2025","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2026.101455_b0055","article-title":"Preterm pre-eclampsiA: PlAcental Growth factor testing for reduction of Adverse Outcomes. National Institute of Healthcare","author":"Shennan","year":"2024","journal-title":"Research"},{"issue":"13","key":"10.1016\/j.preghy.2026.101455_b0060","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/1471-0528.16323","article-title":"Glycosylated fibronectin point\u2010of\u2010care test for diagnosis of pre\u2010eclampsia in a low\u2010resource setting: a prospective Southeast Asian population study","volume":"127","author":"Nagalla","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2026.101455_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-020-2809-2","article-title":"Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study","author":"Huhn","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"10.1016\/j.preghy.2026.101455_b0070","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/uog.27458","article-title":"Prediction using serum glycosylated fibronectin of imminent pre\u2010eclampsia in women with new\u2010onset hypertension","volume":"62","author":"Sokratous","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2026.101455_b0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.21276\/obgyn.2023.9.2.3","article-title":"A cross sectional study to assess the efficacy of glycosylated fibronectin (GlyFn) estimation in prediction of the severity of disease in new onset hypertension in pregnancy from 24 weeks to term","volume":"9","author":"Choudhury","year":"2023","journal-title":"The New Indian Journal of OBGYN."},{"issue":"1","key":"10.1016\/j.preghy.2026.101455_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001589","article-title":"A Risk Prediction Model for the Assessment and Triage of Women with Hypertensive Disorders of Pregnancy in Low-Resourced Settings: The miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Multi-country Prospective Cohort Study","volume":"11","author":"Payne","year":"2014","journal-title":"PLoS Med."},{"key":"10.1016\/j.preghy.2026.101455_b0085","series-title":"Biostatistics - a methodology for the health sciences","first-page":"115","article-title":"Statistical Inference: populations & samples","author":"Fisher","year":"1993"},{"key":"10.1016\/j.preghy.2026.101455_b0090","doi-asserted-by":"crossref","DOI":"10.1080\/14767058.2025.2474674","article-title":"Clinical utility of a glycosylated fibronectin test (Lumella TM) for assessment of impending preeclampsia","author":"Di Renzo","year":"2025","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.preghy.2026.101455_b0095","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-020-2809-2","article-title":"Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study","author":"Huhn","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"10.1016\/j.preghy.2026.101455_b0100","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/uog.29107","article-title":"Intermanufacturer assessment of diagnostic performance of angiogenic ratio vs glycosylated fibronectin in women with suspected pre\u2010eclampsia","volume":"64","author":"Wah","year":"2024","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2026.101455_b0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/uog.27481","article-title":"Screening for pre\u2010eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks\u2019 gestation","volume":"63","author":"Sokratous","year":"2024","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2026.101455_b0110","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/uog.26303","article-title":"Screening for pre\u2010eclampsia by maternal serum glycosylated fibronectin at 11\u221213\u2009weeks\u2019 gestation","volume":"62","author":"Sokratous","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2026.101455_b0115","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/uog.27451","article-title":"Glycosylated fibronectin improves first\u2010trimester prediction of pre\u2010eclampsia","volume":"62","author":"Moungmaithong","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2026.101455_b0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12884-025-07243-6","article-title":"Glycosylated fibronectin in preeclampsia: a systematic review and meta-analysis","volume":"25","author":"Liao","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"10.1016\/j.preghy.2026.101455_b0125","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/1471-0528.18040","article-title":"Point\u2010of\u2010Care Tests for Preeclampsia: Systematic Review and Meta\u2010Analysis of Diagnostic Test Accuracy Studies","volume":"132","author":"Elbarbary","year":"2025","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2026.101455_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.preghy.2024.101177","article-title":"Glycosylated fibronectin as a biomarker for preeclampsia and preeclampsia-related complications","volume":"39","author":"Kluivers","year":"2025","journal-title":"Pregnancy Hypertens."},{"issue":"S1","key":"10.1016\/j.preghy.2026.101455_b0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s13224-021-01566-y","article-title":"Glycosylated Fibronectin Point-of-care Test for Triage and Surveillance of Hypertension in Pregnancy Cases: A Retrospective Observational Case Control Study","volume":"72","author":"Kesireddy","year":"2022","journal-title":"The Journal of Obstetrics and Gynecology of India."},{"issue":"6","key":"10.1016\/j.preghy.2026.101455_b0140","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/uog.27475","article-title":"Prediction using serum glycosylated fibronectin and angiogenic factors of superimposed pre\u2010eclampsia in women with chronic hypertension","volume":"62","author":"Sokratous","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"10399","key":"10.1016\/j.preghy.2026.101455_b0145","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0140-6736(23)00688-8","article-title":"Planned delivery or expectant management for late preterm pre-eclampsia in low-income and middle-income countries (CRADLE-4): a multicentre, open-label, randomised controlled trial","volume":"402","author":"Beardmore-Gray","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.preghy.2026.101455_b0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-093586","article-title":"Comparison of glycosylated fibronectin versus soluble fms-like tyrosine kinase\/placental growth factor ratio testing for the assessment of pre-eclampsia: protocol for a multicentre diagnostic test accuracy study","volume":"15","author":"Elbarbary","year":"2025","journal-title":"BMJ Open"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778926000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778926000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T07:53:55Z","timestamp":1780905235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778926000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"alternative-id":["S2210778926000437"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2026.101455","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of severe maternal and perinatal complications in hypertensive pregnancies using point-of-care glycosylated fibronectin: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2026.101455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}],"article-number":"101455"}}